Par des auto-évaluations, des suivis cliniques et des données de prescription.
Adhérence au traitementSuivi clinique
#3
Quels sont les critères de succès d'un traitement ?
L'amélioration des symptômes et la qualité de vie des patients sont des critères clés.
Critères de succèsQualité de vie
#4
Comment les effets secondaires sont-ils mesurés ?
Ils sont souvent rapportés par les patients et évalués lors des consultations.
Effets secondairesÉvaluation des effets
#5
Quelle est l'importance du suivi post-traitement ?
Il permet d'évaluer la durabilité des effets et d'ajuster les traitements si nécessaire.
Suivi post-traitementAjustement thérapeutique
Complications
5
#1
Comment les complications sont-elles identifiées ?
Elles sont souvent rapportées par les patients et documentées dans les dossiers médicaux.
ComplicationsDossiers médicaux
#2
Quels types de complications peuvent survenir ?
Des complications aiguës et chroniques peuvent survenir selon le traitement.
Complications aiguësComplications chroniques
#3
Comment évaluer l'impact des complications ?
Par l'analyse des résultats cliniques et des effets sur la qualité de vie.
Impact des complicationsQualité de vie
#4
Quelles sont les stratégies de gestion des complications ?
Des protocoles de traitement et des suivis réguliers sont essentiels.
Gestion des complicationsProtocoles de traitement
#5
Comment prévenir les complications ?
Par une surveillance étroite et des interventions précoces lors des traitements.
Prévention des complicationsSurveillance
Facteurs de risque
5
#1
Quels facteurs de risque sont souvent étudiés ?
Les facteurs génétiques, environnementaux et comportementaux sont fréquemment analysés.
Facteurs de risqueAnalyse comportementale
#2
Comment les facteurs de risque influencent-ils les résultats ?
Ils peuvent modifier l'efficacité du traitement et la survenue de complications.
Influence des facteurs de risqueEfficacité du traitement
#3
Comment identifier les facteurs de risque ?
Par des études épidémiologiques et des analyses statistiques des données.
Études épidémiologiquesAnalyse statistique
#4
Quelle est l'importance de la stratification des risques ?
Elle permet de personnaliser les traitements en fonction des caractéristiques des patients.
Stratification des risquesPersonnalisation des traitements
#5
Comment réduire les facteurs de risque ?
Par des interventions ciblées et des changements de mode de vie adaptés.
Réduction des risquesChangements de mode de vie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Études contrôlées avant-après : Questions médicales les plus fréquentes",
"headline": "Études contrôlées avant-après : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Études contrôlées avant-après : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2026-07-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Études contrôlées avant-après"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Études épidémiologiques",
"url": "https://questionsmedicales.fr/mesh/D016021",
"about": {
"@type": "MedicalCondition",
"name": "Études épidémiologiques",
"code": {
"@type": "MedicalCode",
"code": "D016021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Études contrôlées avant-après",
"alternateName": "Controlled Before-After Studies",
"code": {
"@type": "MedicalCode",
"code": "D065187",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Simon M Danner",
"url": "https://questionsmedicales.fr/author/Simon%20M%20Danner",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurobiology and Anatomy, College of Medicine, Drexel University, Philadelphia, PA, USA."
}
},
{
"@type": "Person",
"name": "Courtney T Shepard",
"url": "https://questionsmedicales.fr/author/Courtney%20T%20Shepard",
"affiliation": {
"@type": "Organization",
"name": "Interdisciplinary Program in Translational Neuroscience, University of Louisville School of Medicine, Health Sciences Campus, Louisville, Kentucky, USA."
}
},
{
"@type": "Person",
"name": "Casey Hainline",
"url": "https://questionsmedicales.fr/author/Casey%20Hainline",
"affiliation": {
"@type": "Organization",
"name": "Speed School of Engineering, University of Louisville School of Medicine, Health Sciences Campus, Louisville, Kentucky, USA."
}
},
{
"@type": "Person",
"name": "Natalia A Shevtsova",
"url": "https://questionsmedicales.fr/author/Natalia%20A%20Shevtsova",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurobiology and Anatomy, College of Medicine, Drexel University, Philadelphia, PA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perioperative pain management intervention in older patients with hip fracture in an orthogeriatric unit. A controlled before/after study assessing an audit and feedback intervention (PAIN-AGE).",
"datePublished": "2024-09-05",
"url": "https://questionsmedicales.fr/article/39237920",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12877-024-05282-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of a healthcare students' prevention intervention for school children on their own substance use: a before-after study.",
"datePublished": "2023-11-07",
"url": "https://questionsmedicales.fr/article/37936175",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12909-023-04813-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy - a before-after study.",
"datePublished": "2023-10-26",
"url": "https://questionsmedicales.fr/article/37884860",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-023-08732-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Can video communication in the emergency medical communication centre improve dispatch precision? A before-after study in Norwegian helicopter emergency medical services.",
"datePublished": "2023-10-29",
"url": "https://questionsmedicales.fr/article/37899141",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2023-077395"
}
},
{
"@type": "ScholarlyArticle",
"name": "Postural control before and after transitional locomotor tasks in children on the autism spectrum: A case-control study.",
"datePublished": "2024-04-12",
"url": "https://questionsmedicales.fr/article/38626570",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clinbiomech.2024.106251"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Caractéristiques des études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016020"
},
{
"@type": "ListItem",
"position": 6,
"name": "Études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016021"
},
{
"@type": "ListItem",
"position": 7,
"name": "Études contrôlées avant-après",
"item": "https://questionsmedicales.fr/mesh/D065187"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Études contrôlées avant-après - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Études contrôlées avant-après",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Études contrôlées avant-après",
"description": "Comment évaluer l'efficacité d'un traitement ?\nQuels outils sont utilisés pour le diagnostic ?\nQuelle est l'importance du groupe témoin ?\nComment mesurer les résultats d'une étude ?\nQuelles sont les limites des études avant-après ?",
"url": "https://questionsmedicales.fr/mesh/D065187#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Études contrôlées avant-après",
"description": "Quels symptômes peuvent être évalués ?\nComment les symptômes évoluent-ils après traitement ?\nPeut-on quantifier les symptômes ?\nQuels symptômes sont souvent mesurés ?\nComment les symptômes influencent-ils l'étude ?",
"url": "https://questionsmedicales.fr/mesh/D065187#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Études contrôlées avant-après",
"description": "Comment évaluer l'impact des mesures préventives ?\nQuelles stratégies de prévention sont efficaces ?\nComment mesurer le changement de comportement ?\nQuels indicateurs de santé sont suivis ?\nQuelle est l'importance de l'éducation à la santé ?",
"url": "https://questionsmedicales.fr/mesh/D065187#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Études contrôlées avant-après",
"description": "Quels types de traitements sont évalués ?\nComment évaluer l'adhérence au traitement ?\nQuels sont les critères de succès d'un traitement ?\nComment les effets secondaires sont-ils mesurés ?\nQuelle est l'importance du suivi post-traitement ?",
"url": "https://questionsmedicales.fr/mesh/D065187#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Études contrôlées avant-après",
"description": "Comment les complications sont-elles identifiées ?\nQuels types de complications peuvent survenir ?\nComment évaluer l'impact des complications ?\nQuelles sont les stratégies de gestion des complications ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D065187#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Études contrôlées avant-après",
"description": "Quels facteurs de risque sont souvent étudiés ?\nComment les facteurs de risque influencent-ils les résultats ?\nComment identifier les facteurs de risque ?\nQuelle est l'importance de la stratification des risques ?\nComment réduire les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D065187#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un traitement ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "En comparant les résultats cliniques avant et après l'intervention."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires standardisés et des mesures cliniques sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du groupe témoin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet de comparer les effets de l'intervention avec un groupe non traité."
}
},
{
"@type": "Question",
"name": "Comment mesurer les résultats d'une étude ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des indicateurs quantitatifs et qualitatifs avant et après l'intervention."
}
},
{
"@type": "Question",
"name": "Quelles sont les limites des études avant-après ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être biaisées par des facteurs externes non contrôlés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être évalués ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes cliniques, psychologiques et fonctionnels peuvent être mesurés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils après traitement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'améliorer, se stabiliser ou s'aggraver selon l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Peut-on quantifier les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, par des échelles de mesure validées et des scores cliniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont souvent mesurés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur, la fatigue et l'anxiété sont fréquemment évalués."
}
},
{
"@type": "Question",
"name": "Comment les symptômes influencent-ils l'étude ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent affecter l'adhérence au traitement et les résultats globaux."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des mesures préventives ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "En comparant les taux d'incidence avant et après la mise en œuvre des mesures."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de sensibilisation et les programmes de dépistage sont souvent efficaces."
}
},
{
"@type": "Question",
"name": "Comment mesurer le changement de comportement ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des enquêtes et des évaluations comportementales avant et après l'intervention."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé sont suivis ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs de santé publique comme la prévalence et l'incidence des maladies."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'éducation à la santé ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle joue un rôle clé dans la prévention et l'adoption de comportements sains."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont évalués ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements médicamenteux, chirurgicaux et comportementaux peuvent être étudiés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'adhérence au traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des auto-évaluations, des suivis cliniques et des données de prescription."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de succès d'un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'amélioration des symptômes et la qualité de vie des patients sont des critères clés."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires sont-ils mesurés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent rapportés par les patients et évalués lors des consultations."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du suivi post-traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet d'évaluer la durabilité des effets et d'ajuster les traitements si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles identifiées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont souvent rapportées par les patients et documentées dans les dossiers médicaux."
}
},
{
"@type": "Question",
"name": "Quels types de complications peuvent survenir ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications aiguës et chroniques peuvent survenir selon le traitement."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par l'analyse des résultats cliniques et des effets sur la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de gestion des complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles de traitement et des suivis réguliers sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par une surveillance étroite et des interventions précoces lors des traitements."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont souvent étudiés ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs génétiques, environnementaux et comportementaux sont fréquemment analysés."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils les résultats ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent modifier l'efficacité du traitement et la survenue de complications."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques et des analyses statistiques des données."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la stratification des risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de personnaliser les traitements en fonction des caractéristiques des patients."
}
},
{
"@type": "Question",
"name": "Comment réduire les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des interventions ciblées et des changements de mode de vie adaptés."
}
}
]
}
]
}
Interdisciplinary Program in Translational Neuroscience, University of Louisville School of Medicine, Health Sciences Campus, Louisville, Kentucky, USA.
Publications dans "Études contrôlées avant-après" :
Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki (Hakulinen, Elovainio); National Institute for Health and Welfare, Helsinki (Hakulinen, Elovainio, Arffman, Lumme, Keskimäki, Manderbacka); Faculty of Social Sciences, Tampere University, Tampere, Finland (Suokas, Pirkola, Keskimäki); Pirkanmaa Hospital District, Tampere, Finland (Pirkola); School of Business and Economics, University of Jyväskylä, Jyväskylä, Finland (Böckerman); Labour Institute for Economic Research, Helsinki (Böckerman).
Publications dans "Études contrôlées avant-après" :
Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki (Hakulinen, Elovainio); National Institute for Health and Welfare, Helsinki (Hakulinen, Elovainio, Arffman, Lumme, Keskimäki, Manderbacka); Faculty of Social Sciences, Tampere University, Tampere, Finland (Suokas, Pirkola, Keskimäki); Pirkanmaa Hospital District, Tampere, Finland (Pirkola); School of Business and Economics, University of Jyväskylä, Jyväskylä, Finland (Böckerman); Labour Institute for Economic Research, Helsinki (Böckerman).
Publications dans "Études contrôlées avant-après" :
Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki (Hakulinen, Elovainio); National Institute for Health and Welfare, Helsinki (Hakulinen, Elovainio, Arffman, Lumme, Keskimäki, Manderbacka); Faculty of Social Sciences, Tampere University, Tampere, Finland (Suokas, Pirkola, Keskimäki); Pirkanmaa Hospital District, Tampere, Finland (Pirkola); School of Business and Economics, University of Jyväskylä, Jyväskylä, Finland (Böckerman); Labour Institute for Economic Research, Helsinki (Böckerman).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
From the INSERM UMRS 996 - Intestinal Microbiota, Macrophages and Liver Inflammation, DHU Hepatinov, Clamart, France (Ciocan, Cassard, Voican, Perlemuter); the University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France (Ciocan, Cassard, Becquemont, Verstuyft, Voican, El Asmar, Colle, Trabado, Chanson, Perlemuter, Corruble); the APHP, Hepato-Gastroenterology and Nutrition, Antoine-Béclère Hospital, Clamart, France (Ciocan, Voican, Perlemuter); the Centre for Clinical Research (CRC), Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France (Becquemont); the INSERM UMR-1178, CESP, "MOODS" Team, Le Kremlin-Bicêtre, France (Becquemont, Verstuyft, El Asmar, David, Corruble); the Department of Molecular Genetics, Pharmacogenetics and Hormones, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Becquemont, Verstuyft, Trabado); the Psychiatry Department, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Colle, Corruble); the University Paris-Saclay, University Paris-Sud, Faculty of Pharmacy, Chatenay-Malabry, 92 296, France (David); the INSERM 1185, University Paris-Saclay, University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, 94276, France (Trabado, Chanson); the Department of Endocrinology, Saint-Antoine Hospital, AP-HP, Sorbonne University, University Paris 6, Paris, France (Feve); the INSERM UMR S_938, Saint-Antoine Research Centre, Paris, France (Feve); and the Department of Endocrinology and Reproductive Diseases, Kremlin-Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, 94275, France (Chanson).
Publications dans "Études contrôlées avant-après" :
Postoperative pain delays ambulation, extends hospital stay, reduces the probability of recovery, and increases risk of long-term functional impairment. Pain management in hip fractured patients poses...
We conducted a controlled before/after study to assess the ability of an audit and feedback (A&F) intervention built with nurses to improve the quality of perioperative pain management in older patien...
We studied data from 397 patients (mean age 89 years, 75% female). During the postoperative period, 16% of patients from the experimental group received 3 g/day of acetaminophen before the A&F interve...
Our controlled before/after study showed that an A&F intervention significantly improved perioperative pain management in older adults hospitalized for hip fracture. Involving teams in continuous educ...
Cognitive dissonance theory and research has suggested that engaging in prevention interventions for other students may be a means of reducing one's own problematic behaviors in order to reduce potent...
Healthcare students were trained in a French university to develop psychosocial competences as a health promotion means (FEPS training) or more specifically to prevent substance use in teenagers (Unpl...
The results indicated a significant reduction in alcohol consumption in terms of quantity, but no significant reduction in tobacco and marijuana consumption....
This study showed that, contrary to the usual increase in substance use in students as they advance in their year, the students who took part in this study showed reduced self-reported consumption of ...
The BioFire® FilmArray® Blood Culture Identification Panel 1 (BF-FA-BCIP) detects microorganisms with high accuracy in positive blood cultures (BC) - a key step in the management of patients with susp...
In this retrospective single-centre study with a before-after design, 386 positive BC cases with identification by BF-FA-BCIP were compared to 414 controls with culture-based identification. The prima...
Baseline characteristics of included adult inpatients were comparable. Main sources of bacteraemia were urinary tract and intra-abdominal infection (19.2% vs. 22.0% and 16.8% vs. 15.7%, for cases and ...
Rapid microorganism identification by BF-FA-BCIP was associated with a median 20-h earlier initiation of OAT in patients with positive BC. No impact on length of stay and mortality was noted....
Clinicaltrials.gov, NCT04156633, registered on November 5, 2019....
Dispatching helicopter emergency medical services (HEMS) to the patients with the greatest medical or logistical benefit remains challenging. The introduction of video calls (VC) in the emergency medi...
An observational before-after study....
The regional EMCC and one HEMS base in Mid-Norway....
EMCC operators and HEMS physicians at the EMCC and HEMS base in Trondheim, Norway....
In January 2022, VC became available in emergency calls in Trondheim EMCC. Data were collected from 2020 2021 (pre-intervention) and 2022 (post-intervention)....
The primary outcome was the proportion of seriously ill or injured HEMS patients, defined as a National Advisory Committee for Aeronautics (NACA) score between 4 and 7. The secondary outcome was the p...
811 and 402 HEMS missions with patient contact were included in the pre- and post-intervention group, respectively. The proportion of missions with NACA 4-7 was not significantly changed after the int...
The results from this study indicate that VC is a promising, feasible and safe tool for EMCC operators in the complex HEMS dispatch process....
Instrumented measurements of postural control provide a more accurate insight into the motor development of children with autism. This study aimed to identify postural control deficits in autistic chi...
Sixteen autistic children aged 6-10 but without a comorbidity diagnosis, were enrolled in the study group. The control group comprised 16 typically developing peers. The assessment of the transitional...
The two-way ANOVA with a 2 × 4 factorial design (group × testing condition) revealed a group effect on all posturographic variables in the antero-posterior and medio-lateral directions of phase 1 and ...
Autistic children show increased postural sway before and after transitional locomotor tasks compared to typically developing children. The trial was prospectively registered in the Australian and New...
Clarifying the effectiveness of co-teaching in medicine and nursing (CMN) is important as it is crucial in clinical practice to improve the quality of patient care and prognosis. In this study, we aim...
The study comprised a 6-month training session and a before-and-after controlled study. In total, 59 nurses were recruited. The first 30 nurses were enrolled in the conventional single-teaching in nur...
Participants in the CMN group outperformed those in the SN group in tests of medical and nursing collaboration abilities as well as knowledge. The CMN group outperformed the SN group in terms of teach...
In comparison to the SN group, the CMN group had enhanced outcomes of patient care, medical and nursing collaboration, and clinical reasoning skills....
The biomechanical characteristics of proximal femoral trabeculae are closely related to the occurrence and treatment of proximal femoral fractures. Therefore, it is of great significance to study its ...
Seventeen proximal femoral specimens were selected to scan by quantitative computed tomography (QCT), and the gray values of nine regions were measure to evaluated bone mineral density (BMD) using Mim...
There was a statistically significant difference in anteroposterior displacement of cancellous bone destruction in the proximal femur (p < 0.001). Proximal femoral bone mass explained 77.5% of the str...
The trabecular removal significantly altered the strain distribution and biomechanical strength of the proximal femur, demonstrating an important role in supporting and transforming bending moment und...
Some individuals experience prolonged illness after acute COVID-19. We assessed whether pre-infection symptoms affected post-COVID illness duration....
Survival analysis was performed in adults (n=23 452) with community-managed SARC-CoV-2 infection prospectively self-logging data through the ZOE COVID Symptom Study app, at least weekly, from 8 weeks ...
Individuals reporting baseline symptoms had longer post-COVID symptom duration (from 10 to 15 days) with baseline fatigue nearly doubling duration. Two-thirds (910 of 1350 [67.4%]) of individuals with...
Individuals experiencing symptoms before COVID-19 have longer illness duration and increased odds of long illness. However, many individuals with long illness are well before SARS-CoV-2 infection....
To evaluate and explore the feasibility of using quality control indicators for nutritional therapy in critically ill patients as quality evaluation criteria....
This study focused on intensive care unit (ICU) critically ill patients and conducted a cross-sectional investigation of nutritional therapy quality control indicators (the proportion of patients with...
(1) A total of 631 patients were included before and after training, with a data acquisition rate of 97.3% for enteral nutrition pumps usage and complete data collection for the remaining nutritional ...
The five quality control indicators for nutritional therapy in critically ill patients are clinically feasible and can be used as quality evaluation criteria for nutritional therapy in critically ill ...
The traditional practice of administrating neuromuscular blocking drugs (NMBDs) after checking face mask ventilation is challenged repeatedly. This study compared the efficiency of face mask ventilati...
After ethical approval, patients (n = 120) in the age group of 18-65 years scheduled for elective surgery under general anaesthesia were randomly assigned into two groups. Group 1 received an NMBD bef...
For a total of 180 seconds of mask ventilation, the mean (standard deviation) Vte measured after apnoea was significantly higher in Group 1 versus Group 2 [471.9 (63.3) vs 434.8 (77.0) mL/breath,...
The administration of NMBDs resulted in a larger mask Vte and shorter intubation time....